Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 601–650 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
CVRXCVRx, Inc. Healthcare Nov 5 Sep '26 $14.0M −6.7% −$14.0M n/m −$0.52 n/m -94.3% −10.8 pp $17M
ATYRaTyr Pharma, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$18.0M n/m −$7.43 n/m — — $12M
SINTSiNtx Technologies, Inc. Healthcare Nov 5 Sep '26 $2.0M n/m −$2.0M n/m −$0.24 n/m -74.7% — $9M
INABIN8bio, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$5.0M n/m −$0.24 n/m — — $9M
PHIOPhio Pharmaceuticals Corp. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.36 n/m — — $9M
INTSIntensity Therapeutics, Inc. Healthcare Nov 5 Sep '26pending — — — — — — — — $7M
ACHAccendra Health, Inc. Healthcare Nov 5 Sep '26 $602M −13.6% −$20.0M n/m $0.00 n/m 0.2% −7.9 pp $7M
REVBRevelation Biosciences, Inc. Healthcare Nov 5 Sep '26pending — — — — — — — — $2M
NVONovo Nordisk A/S Healthcare Nov 4 Sep '26 $11.90B +5.6% — −16.3% $0.89 −15.8% 29.1% −2.5 pp $179.4B
MCKMcKesson Corporation Healthcare Nov 4 Sep '26 $110.96B +7.6% $1.22B +9.7% $10.44 +17.0% 1.4% +0.0 pp $126.0B
CVSCVS Health Corporation Healthcare Nov 4 Sep '26 $108.40B +5.4% $2.17B n/m $1.68 n/m 3.3% +6.4 pp $109.8B
CORCencora, Inc. Healthcare Nov 4 Sep '26 $88.36B +5.5% $519M n/m $2.71 n/m 1.0% +0.0 pp $66.9B
EWEdwards Lifesciences Corporation Healthcare Nov 4 Sep '26 $1.72B +10.5% $308M +5.8% $0.53 +6.0% 17.4% −9.9 pp $60.6B
RVMDRevolution Medicines, Inc. Healthcare Nov 4 Sep '26 $198M n/m −$407M n/m −$1.90 n/m -188.9% — $35.2B
MDLNMedline Inc. Healthcare Nov 4 Sep '26 $7.86B +10.4% $195M −39.4% $0.15 −63.4% 6.4% −1.7 pp $33.1B
RPRXRoyalty Pharma plc Healthcare Nov 4 Sep '26 $690M +13.3% $145M −49.7% $0.26 −61.2% 59.6% −10.5 pp $30.6B
STESTERIS plc (Ireland) Healthcare Nov 4 Sep '26 $1.59B +8.8% $214M +11.5% $2.19 +12.9% 18.5% +0.2 pp $25.0B
UTHRUnited Therapeutics Corporation Healthcare Nov 4 Sep '26 $833M +4.1% $259M −23.6% $5.71 −20.3% 37.0% −11.7 pp $24.9B
ZBHZimmer Biomet Holdings, Inc. Healthcare Nov 4 Sep '26 $2.06B +3.1% $192M −16.9% $1.00 −13.8% 14.9% −2.6 pp $19.3B
CRLCharles River Laboratories International, Inc. Healthcare Nov 4 Sep '26 $983M −2.2% $333M +516.7% $6.86 +523.6% 20.6% +7.3 pp $15.9B
BIO.BBio-Rad Laboratories, Inc. Healthcare Nov 4 Sep '26 $656M +0.5% $459M n/m $17.02 n/m -7.6% −17.7 pp $10.4B
QGENQiagen N.V. Healthcare Nov 4 Sep '26 $548M +2.8% $106M −18.5% $0.51 −15.0% 27.7% +3.4 pp $10.3B
PODDInsulet Corporation Healthcare Nov 4 Sep '26 $842M +19.3% $141M +60.2% $2.03 +63.7% 22.5% +5.9 pp $10.1B
BIOBio-Rad Laboratories, Inc. Healthcare Nov 4 Sep '26 $656M +0.5% $459M n/m $17.02 n/m -7.6% −17.7 pp $9.6B
PCVXVaxcyte, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$297M n/m −$1.99 n/m — — $9.4B
BRKRBruker Corporation Healthcare Nov 4 Sep '26 $874M +1.5% −$112M n/m −$0.81 n/m -10.4% −14.5 pp $9.4B
SMMTSummit Therapeutics Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$208M n/m −$0.26 n/m — — $8.5B
CYTKCytokinetics, Incorporated Healthcare Nov 4 Sep '26 $48.0M +2,300% −$190M n/m −$1.37 n/m -352.3% — $7.2B
CAICaris Life Sciences, Inc. Healthcare Nov 4 Sep '26 $275M +26.7% $15.0M −37.5% $0.05 −37.5% 7.0% −8.0 pp $5.7B
LIVNLivaNova PLC Healthcare Nov 4 Sep '26 $393M +9.8% $34.0M +25.9% $0.60 +22.4% 7.2% −7.9 pp $5.1B
DNTHDianthus Therapeutics, Inc. Healthcare Nov 4 Sep '26 $1.0M n/m −$47.0M n/m −$0.81 n/m — — $4.9B
GRALGRAIL, Inc. Healthcare Nov 4 Sep '26 $38.0M +5.6% −$104M n/m −$2.21 n/m -385.3% −39.1 pp $4.8B
OPCHOption Care Health, Inc. Healthcare Nov 4 Sep '26 $1.49B +4.1% $57.0M +9.6% $0.38 +18.8% 6.0% +0.1 pp $4.7B
BLLNBillionToOne, Inc. Healthcare Nov 4 Sep '26 $123M +46.4% $17.0M +750.0% $0.32 +220.0% 9.0% −2.6 pp $4.7B
ADPTAdaptive Biotechnologies Corporation Healthcare Nov 4 Sep '26 $84.0M −10.6% $3.0M −70.0% $0.02 −66.7% -0.5% −11.5 pp $4.6B
EWTXEdgewise Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m $1.17B n/m $9.65 n/m — — $4.5B
NVSTEnvista Holdings Corporation Healthcare Nov 4 Sep '26 $692M +3.3% $508M n/m $3.11 n/m 74.5% +64.8 pp $3.8B
RLAYRelay Therapeutics, Inc. Healthcare Nov 4 Sep '26 $0.0M n/m −$82.0M n/m −$0.37 n/m — — $3.6B
ACHCAcadia Healthcare Company, Inc. Healthcare Nov 4 Sep '26 $895M +5.0% $34.0M −5.6% $0.38 −5.0% 12.7% −1.3 pp $3.5B
ARQTArcutis Biotherapeutics, Inc. Healthcare Nov 4 Sep '26 $144M +45.5% $9.0M +28.6% $0.06 0.0% 6.6% −2.0 pp $3.5B
VRDNViridian Therapeutics, Inc. Healthcare Nov 4 Sep '26 $26.0M −63.4% −$101M n/m −$0.81 n/m -401.8% −345.1 pp $3.4B
ACADACADIA Pharmaceuticals Inc. Healthcare Nov 4 Sep '26 $342M +22.6% $54.0M −25.0% $0.31 −26.2% 20.9% +8.1 pp $3.2B
ADMAADMA Biologics Inc Healthcare Nov 4 Sep '26 $141M +5.2% $50.0M +38.9% $0.22 +46.7% 48.0% +10.0 pp $3.0B
PGNYProgyny, Inc. Healthcare Nov 4 Sep '26 $341M +8.9% $26.0M +85.7% $0.32 +113.3% 10.3% +3.4 pp $2.7B
XNCRXencor, Inc. Healthcare Nov 4 Sep '26 $117M +457.1% $39.0M n/m $0.50 n/m 19.6% +245.9 pp $2.6B
CLOVClover Health Investments, Corp. Healthcare Nov 4 Sep '26 $759M +52.7% $6.0M n/m $0.01 n/m 0.8% +5.8 pp $2.5B
ARDTArdent Health, Inc. Healthcare Nov 4 Sep '26 $1.63B +3.0% $45.0M n/m $0.31 n/m 5.9% −10.3 pp $2.5B
RCUSArcus Biosciences, Inc. Healthcare Nov 4 Sep '26 $9.0M n/m −$128M n/m −$1.00 n/m — — $2.4B
NAMSNewAmsterdam Pharma Company N.V. Healthcare Nov 4 Sep '26 $19.0M n/m −$17.0M n/m −$0.14 n/m -230.6% — $2.3B
PRGOPerrigo Company plc Healthcare Nov 4 Sep '26 $989M −5.2% −$27.0M −437.5% −$0.20 −500.0% 2.3% −4.6 pp $2.2B
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.